Healthy aging is a lifelong investment

Yoxlo’s patented research has unlocked the key to prolonging good health as we age

Rethinking old age

From Diseasespan to Healthspan

•• •

We're living longer than ever—but too often, those extra years are spent in poor health. While medicine has extended lifespan, our healthspan has not kept pace. The result? A growing “diseasespan”: the final decade, or more, of life marked by chronic illness and loss of independence.

YOXLO aims to change that—by developing science-based inter- ventions that target the root causes of aging, improving cellular function and mitochondrial efficiency to help preserve vitality longer.

Supporting YOXLO means investing in a future where aging is defined by vitality—not decline.

Support our next level of research →

Targeting Healthspan with Youngenine

our vission

Closing the gap between healthspan and lifespan

Some people live beyond 100 in remarkably good health—free from chronic illness, physically active, mentally sharp. These healthy centenarians show us what's biologically possible, yet for most people, the final years of life are defined by disease and decline.

At YOXLO, we’re working to close that gap. Our mission is to help more people experience long lives in good health—not just the lucky few.

INSPIRED BY BIOLOGY. DRIVEN BY SCIENCE
Healthy centenarians aren't just lucky. Their resilience is rooted in biology—traits we can learn from and hopefully replicate. At YOXLO, we develop science-based interventions that target the underlying mechanisms of aging, aiming to extend vitality, strength, and independence well into old age.

YOUNGENINE: A NEW FRONTIER IN HEALTHY AGING
Youngenine is our flagship innovation—a next-generation formulation designed to address key biological drivers of aging. By supporting mitochondrial and cellular function, it holds the potential to add more healthy, active years to life.

With Youngenine, we aim to help more people maintain vitality and independence as they age.

INVEST IN THE FUTURE OF HEALTHSPAN
Supporting YOXLO means investing in a future where aging is defined by vitality, not decline. Learn more about how you can join us in building that future. Learn more about how you can join us in building that future.

•• •

Keep on doing what you love. For longer.

our mission

We turn breakthrough science into practical solutions to slow aging and help people stay healthier for longer.

•• •

YOXLO is a Dutch research-driven company developing novel, science-based interventions to extend human healthspan.

We focus on addressing fundamental biological drivers of aging, including mitochondrial and cellular dysfunction.

Our first formulation targets multiple aging pathways with a proprietary blend of bioactive compounds. Preclinical results are promising, and early-stage human studies are underway.

Stef Verlinden

Founder, CEO and Chief Innovation Officer

“Dr. Verlinden imagines a future in which we could delay the inevitable, staying youthful and active for longer than ever before”.

YOXLO was founded by Dr. Stef Verlinden, a biotech veteran and aging researcher. He is joined by co-founders René den Admirant, a commercial strategist with decades of experience in supplement brand building; Louis Kock, a specialist in operational scaling and e-commerce logistics; and Julliet Smit, a legal expert in intellectual property and regulatory affairs.

Together, they combine deep expertise in biotech, business, and compliance—united by a mission to compress morbidity and promote longer, healthier lives.

We strive for a fantastic life for all people, and will continue to develop novel insights and products to shrink the difference in healthspan between common people and high-performing centenarians.

Supporting Yoxlo’s research and development is an investment in both your long-term health and in the science of healthy aging.

Challenging the conventional

Yoxlo is a pioneer in the science of healthy aging.

Passion for progress

Our curiosity drives high expectations in research.

Life is extraordinary

Life is too short to be ordinary. Live it to the fullest.

Join us in Advancing Healthspan.

funding

Are you an investor with a vision for the future of healthy aging?

•• •

Yoxlo is actively seeking investors who are equally passionate about the science of better aging and prolonging their own good health. For updates on how you can support the next level of research on Youngenin and be among the first to enjoy its benefits, join our list or email us via the form below.